Clinical Trial Update: End-organ Pathology in Childhood Essential Hypertension

View source ↗

Summary

An NHLBI-sponsored clinical trial investigating end-organ pathology in childhood essential hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Heart Diseases
• Hypertension

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Heart Diseases | Status: COMPLETED